fbpx
September 29, 2020

Increased Risk of Severe COVID With Anti-B-Cell MS Drugs? Increased Risk of Severe COVID With Anti-B-Cell MS Drugs?

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Concerns are being raised over an increased risk of severe COVID-19 outcomes […]
September 28, 2020

Nerve Damage Linked to Prone Positioning in COVID-19 Nerve Damage Linked to Prone Positioning in COVID-19

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Among COVID-19 patients who undergo mechanical ventilation, lying in the prone position […]
September 23, 2020

Survey IDs Barriers to Minority Participation in PD Research Survey IDs Barriers to Minority Participation in PD Research

A new study has identified several barriers to participation of minority patients in studies of Parkinson’s disease (PD). Minority communities are typically underrepresented in research studies, […]
September 23, 2020

Alemtuzumab: Prior Autoimmunity Does Not Predict Adverse Events Alemtuzumab: Prior Autoimmunity Does Not Predict Adverse Events

There is no evidence to support the idea that previous autoimmunity before or after alemtuzumab treatment predicts subsequent rare but serious and possibly life-threatening autoimmune events […]
September 22, 2020

Low-Level Light Therapy Safe for TBI in Humans Low-Level Light Therapy Safe for TBI in Humans

One of the first randomized controlled trials of its kind has concluded that low-level light therapy is safe in the treatment of moderate traumatic brain injury […]
September 21, 2020

Flecainide Plus Modafinil Relieves Sleepiness in Parkinson’s Flecainide Plus Modafinil Relieves Sleepiness in Parkinson’s

Adding a low dose of the anti-arrhythmic drug flecainide to modafinil alleviated excessive daytime sleepiness (EDS) in some patients with Parkinson’s disease (PD), a new study […]
September 21, 2020

Safety Concern With Fingolimod to Ocrelizumab Switch in MS Safety Concern With Fingolimod to Ocrelizumab Switch in MS

A new study suggests the need for caution in switching from fingolimod to a B cell–depleting anti-CD20 treatment such as ocrelizumab for patients with multiple sclerosis (MS). […]
September 21, 2020

CGRPs Promising for Prevention of Chronic Cluster Headache CGRPs Promising for Prevention of Chronic Cluster Headache

Treatment with calcitonin gene-related peptide (CGRP) monoclonal antibodies may reduce the frequency of chronic cluster headache (CCH) attacks in patients with an inadequate response to other […]
September 18, 2020

Researchers Identify Five Cognitive Phenotypes in MS Researchers Identify Five Cognitive Phenotypes in MS

Researchers have identified five cognitive phenotypes among patients with multiple sclerosis (MS). The lead researcher described the clinical characteristics and MRI findings unique to each phenotype […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0